LifeStance Health (LFST) Gross Margin (2020 - 2024)
LifeStance Health (LFST) has disclosed Gross Margin for 5 consecutive years, with 32.12% as the latest value for Q3 2024.
- On a quarterly basis, Gross Margin rose 313.0% to 32.12% in Q3 2024 year-over-year; TTM through Sep 2024 was 31.2%, a 317.0% increase, with the full-year FY2023 number at 28.62%, up 104.0% from a year prior.
- Gross Margin was 32.12% for Q3 2024 at LifeStance Health, up from 31.31% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 63.99% in Q4 2021 to a low of 26.69% in Q1 2022.
- A 5-year average of 31.87% and a median of 30.22% in 2021 define the central range for Gross Margin.
- Peak YoY movement for Gross Margin: crashed -3665bps in 2022, then skyrocketed 397bps in 2024.
- LifeStance Health's Gross Margin stood at 32.49% in 2020, then surged by 97bps to 63.99% in 2021, then crashed by -57bps to 27.33% in 2022, then increased by 9bps to 29.69% in 2023, then increased by 8bps to 32.12% in 2024.
- Per Business Quant, the three most recent readings for LFST's Gross Margin are 32.12% (Q3 2024), 31.31% (Q2 2024), and 31.53% (Q1 2024).